During the past decade, Princeton Medical Institute conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 12 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princeton Medical Institute" #1 sponsor was "Allergan" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "H. Lundbeck A/S" with 2 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princeton Medical Institute" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator and "INC Research Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Princeton Medical Institute" are "Alzheimer Disease" (9 trials), "Alzheimer's Disease" (6 trials), "Depressive Disorder, Major" (2 trials), "Major Depressive Disorder" (2 trials) and "Migraine, With or Without Aura" (2 trials). Many other conditions were trialed in "Princeton Medical Institute" in a lesser frequency.

Most popular intervention types in "Princeton Medical Institute" are "Drug" (31 trials), "Other" (3 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo Control" (2 trials) and "Placebo-matching Ubrogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Princeton Medical Institute" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Princeton Medical Institute". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Princeton Medical Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Princeton Medical Institute, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".